Medical News

RSS

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.

20 Sep 2011

Study explores differences in referral decisions between primary care and specialist physicians

How do physicians decide which colleague to refer their patient to? It differs depending on whether you ask primary care or specialist physicians, according to research from Harvard Medical School, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center in Boston, USA, led by Michael Barnett.

20 Sep 2011

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body's own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.

20 Sep 2011

New UCSB technology can identify cancerous prostate cells

A team of researchers at UC Santa Barbara has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy.

20 Sep 2011

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

A new toll-free helpline developed to help pregnant women avoid medications and other substances that can cause birth defects has been launched by The University of Texas Health Science Center at Houston (UTHealth) for the Texas Department of State Health Services.

20 Sep 2011

Neurocritical Care Society announces comprehensive set of guidelines on brain aneurysms

The Neurocritical Care Society is releasing a comprehensive set of guidelines this week to guide physicians and hospitals on how to optimally care for patient's ruptured brain aneurysms. One of the strongest recommendations is that all patients receive specialized care at high-volume stroke centers that treat at least 60 cases per year.

20 Sep 2011

Roundup: Calif. woman's death at nursing home probed; Minn. orders counseling before patients get long-term care

Johnnie Esco died after a 13-day stay at the El Dorado Care Center in Placerville. Her death on March 7, 2008, led to a contentious civil lawsuit, investigations by California's Department of Justice and Department of Public Health – and the exhumation of her body from Arlington National Cemetery. Last week, amid inquiries from The Bee, the state Department of Justice reopened its criminal investigation into Johnnie Esco's treatment at the facility.

20 Sep 2011

ACR launches Simple Tasks campaign to raise awareness on rheumatic diseases

The American College of Rheumatology has launched its Simple Tasks campaign. The initiative aims to raise awareness of the severe impact of rheumatic diseases - such as rheumatoid arthritis, lupus and gout - on the U.S. population and to highlight the importance of rheumatologists in the diagnosis and treatment of these diseases.

20 Sep 2011

UNC researchers develop technique that can observe cellular intricacies of CF

When researchers discovered the primary genetic defect that causes cystic fibrosis (CF) back in 1989, they opened up a new realm of research into treatment and a cure for the disease. Since then, scientists have been able to clone the defective gene and study its effects in animals. Now researchers at the University of North Carolina at Chapel Hill have developed a technique for observing the defects at work in human tissue donated by patients with CF.

20 Sep 2011

Calgary researchers discover new class of anti-inflammatory agents

By using a mouse model of inflammation researchers at the University of Calgary have discovered a new class of molecules that can inhibit the recruitment of some white blood cells to sites of inflammation in the body.

20 Sep 2011

CMA announces winners of Canada's premier health journalism awards

The Canadian Medical Association (CMA) is proud today to announce the recipients of the 2011 Media Awards for Health Reporting, Canada's premier health journalism awards.

20 Sep 2011

Powerful new antibiotic treatment for MRSA and C. difficile bugs

MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly MRSA and Clostridium difficile (C. diff.) bugs.

20 Sep 2011

OvaGene's new molecular diagnostics laboratory receives CLIA-certification

OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.

20 Sep 2011

MDA, IMRIS collaborate to advance development of MR guided surgical robot

IMRIS Inc. and MacDonald, Dettwiler and Associates Ltd. today announced an agreement for the final phases of collaborative development of IMRIS's MR guided surgical robot, building on the development work the two companies have completed to date.

20 Sep 2011

FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection

Watson Pharmaceuticals, Inc. today announced that Amphastar Pharmaceuticals, Inc., has received U.S. Food and Drug Administration approval of its Abbreviated New Drug Application (ANDA) for Enoxaparin Sodium Injection in the 100mg/mL and 150mg/mL strengths.

20 Sep 2011

Keryx completes enrollment in Zerenex Phase 3 long-term study for hyperphosphatemia

Keryx Biopharmaceuticals today announced completion of patient enrollment in the long-term study component of its Phase 3 registration program of Zerenex, the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis.

20 Sep 2011

GlobalPost examines GHI in Kenya

As part of its special report "Healing the World," GlobalPost examines how the Obama administration's Global Health Initiative (GHI) is affecting U.S. health-related work in Kenya.

20 Sep 2011

ADHD symptoms might affect adaptive abilities, quality of life for children with ASD

Research supported by the Autism Speaks Autism Treatment Network (ATN), demonstrating that symptoms of attention deficit and hyperactivity worsen quality of life for individuals with autism spectrum disorders (ASD), was presented today at the Society for Developmental & Behavioral Pediatrics Annual Meeting in San Antonio, Texas.

20 Sep 2011

Infant formulas fortified with LCPUFA are good for developing brains and hearts

University of Kansas scientists have found new evidence that infant formulas fortified with long chain polyunsaturated fatty acids (LCPUFA) are good for developing brains and hearts.

20 Sep 2011

LA BioMed andrologist leads new male contraceptive Phase I clinical study

Christina Wang, M.D., lead investigator at Los Angeles Biomedical Research Institute (LA BioMed) - one of the leading biomedical research institutes in the country - is currently working on a Phase I single dose and multiple dose study that tests the safety and tolerability of a new androgen dimethandrolone undecanoate that is being developed as a potential male contraceptive agent.

20 Sep 2011

Medical News

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

Study explores differences in referral decisions between primary care and specialist physicians

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

New UCSB technology can identify cancerous prostate cells

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

Neurocritical Care Society announces comprehensive set of guidelines on brain aneurysms

Roundup: Calif. woman's death at nursing home probed; Minn. orders counseling before patients get long-term care

ACR launches Simple Tasks campaign to raise awareness on rheumatic diseases

UNC researchers develop technique that can observe cellular intricacies of CF

Calgary researchers discover new class of anti-inflammatory agents

CMA announces winners of Canada's premier health journalism awards

Powerful new antibiotic treatment for MRSA and C. difficile bugs

OvaGene's new molecular diagnostics laboratory receives CLIA-certification

MDA, IMRIS collaborate to advance development of MR guided surgical robot

FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection

Keryx completes enrollment in Zerenex Phase 3 long-term study for hyperphosphatemia

GlobalPost examines GHI in Kenya

ADHD symptoms might affect adaptive abilities, quality of life for children with ASD

Infant formulas fortified with LCPUFA are good for developing brains and hearts

LA BioMed andrologist leads new male contraceptive Phase I clinical study

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News